Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Total Assets: ₺792.6 Mil (As of Mar. 2026)


IST:ONCSM Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
80 GF Score
Price ₺252.00
GF Value ₺252.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Assets?

Oncosem Onkolojik Sistemlernayi ve Ticaret AS IST:ONCSM +0.40% 80 Total Assets is ₺792.6 Mil as of Mar. 2026. GuruFocus rates IST:ONCSM with a GF Score™ of 80/100 and a GF Value™ of ₺252.15 (Fairly Valued). The stock has 4 warning signs investors should review.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Assets for the quarter that ended in Mar. 2026 was ₺792.6 Mil.

During the past 12 months, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's average Total Assets Growth Rate was 91.20% per year. During the past 3 years, the average Total Assets Growth Rate was 20.60% per year. During the past 5 years, the average Total Assets Growth Rate was 39.90% per year.

During the past 7 years, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's highest 3-Year average Total Assets Growth Rate was 52.90%. The lowest was 20.60%. And the median was 49.90%.

Total Assets is connected with ROA %. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's annualized ROA % for the quarter that ended in Mar. 2026 was 3.36%. Total Assets is also linked to Revenue through Asset Turnover. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Asset Turnover for the quarter that ended in Mar. 2026 was 0.34.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS  (IST:ONCSM) Total Assets Explanation

Total Assets is connected with ROA %.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=23.78/( (624.16+792.572)/ 2 )
=23.78/708.366
=3.36 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=239.002/( (624.16+792.572)/ 2 )
=239.002/708.366
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Assets Related Terms

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Assets Historical Data

* Premium members only.

The historical data trend for Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Assets Chart

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 129.55 349.58 488.45 501.24 624.16

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 426.43 472.37 545.50 624.16 792.57
IST:ONCSM
80GF Score
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=407.003+217.157
=624.2

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=447.25+345.322
=792.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of ₺792.6 Mil mean?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) has a Total Assets of ₺792.6 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Assets too high?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Total Assets is ₺792.6 Mil. Overall, Oncosem Onkolojik Sistemlernayi ve Ticaret AS has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Assets compare to ABT and SYK?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Assets of ₺792.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Total Assets is ₺792.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) is currently considered Fairly Valued. The stock's GF Value™ is ₺252.15, compared to a current price of ₺252.00 — trading 0.1% below its estimated fair value. The current Total Assets is ₺792.6 Mil. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM), the current Total Assets is ₺792.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Overvalued in 2026?

Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock appears to be undervalued. The current stock price of ₺252.00 is trading 0.1% below its estimated GF Value™ of ₺252.15. GuruFocus considers Oncosem Onkolojik Sistemlernayi ve Ticaret AS to be Fairly Valued.

Key valuation signals for IST:ONCSM:

  • Total Assets: ₺792.6 Mil
  • GF Value™: ₺252.15 vs. price of ₺252.00 (0.1% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the IST:ONCSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description

Address Mutlukent Mah. 1988 Cad. No: 12, Cankaya, Ankara, TUR
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.
80GF Score

Get the complete analysis for IST:ONCSM

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺252.00
Price
₺252.15
GF Value